FDA Investigator Philip E Ake

Philip E Ake has inspections in 1 countries as of 13 Sep 2023. Philip E Ake has collaborated with a combinined 3158 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
87
Last Inspection Date:
13 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
100009117
Country:
United States of America
Co-Investigator(s):
A Williams, Adamsr, Alan D Grupe, Amanda S Zorn, Andrew M Kolenc, Andrew S Johnson, Anita Narula, PhD, Arie C Menachem, Astrida B Mattson, Avery J Dennis, Becky Bhan, Betty K Baxter, Blake R Jensen, Brandon K Lawson, Brenda K Alford, Brenda L Reihing, Brent W Higgs, Bruce R Burrell, Bryan J Love, Bryce E Mansfield, Burnell M Henry, Camille Bennett Hoffman, Catherine J Laufmann, Celia L Hutchinstein, Christin L Torres, Christina V Santos, Christine I Shaw, Christine L Williams, Christopher R Czajka, Christopher S Genther, Cynthia Jim, CSO, Cynthia L Gorveatt, Daniel J Lahar, Dawn E Barkans, Deborah A Nebenzahl, Debra L Curtis, Denicia L Hernandez, Denise M Zavagno, Dennis G Kawabata, Dennis R Hudson, Dirk L Lincoln, Dolores E Price, Don A Brunssen, Donald B Mckechnie, Dr. Guang Gao, PhD, Elaine G Stewart, Elisa J Beard, Elizabeth A Sheller, Elizabeth S Howell, Eric C Milstead, Felix J Marrero, Gary C Pecic, Gary L Zaharek, Gene D Arcy, Gerard T Schneider, Ginger M Sykes, Grace E Mcnally, Graham N Giesen, Hanna L Potter, Harperd, Heika R Tait, Holly L Miller, Hugh Grimoldby, Indigo A Doll, Isabel Y Espinosa, Isaiah D Isakson, Ismael Olvera, IV, James D Hildreth, James D Romero, James P Stallings, James R Montero, Jamie L Dion, Jamie L Port, Janet Pulver, Jeanne Weishaar, Jennifer A Robinson, Jennifer L Wolfe, Jessica B Clark, Jessica M Ector, Jessie E Morris, Jinkee Mvila Binayug, Jinkee Mvila Dinayug, John A Hall, John W Banks, Joie A Riehle, Jonathan R Campos, Jonathan T Little, Jose O Caraballo Rivera, Julie A Stocklin, Justin H Erickson, K Gonzlez, Katherine L Arnold, Kathleen S Tormey, Kevin T Gerrity, Kimberley A Hoefen, Kimberly J Proctor Jones, Kimetha A King, Lance W Bohm, Larisa E Pavlick, Larry Gehring, Laura B Kennedy, Lavender M Huskey, Lesley A Swanson, Lewis K Antwi, Leya A Grosch, Linda F Murphy, Linda M Cheny, Lori A Carr, Lori J Silverstein, Manuel A Moreno, Marc A Jackson, Jr, Margaret M Annes, Marie Bbuen Bigornia, Mark E Imsland, Mark E Moen, Martina E Lagrange, Matthew A Johnson, Matthew D Feist, Matthew J Hansen, Matthew M Vernon, Melissa F Chauvin, Michael E Maselli, Michael F Schuette, Michael J Donovan, Michael R Goga, Michelle S Swanson, Mihaly S Ligmond, Morie Alpha, Msdap Gonzlezk, Nancy A Saxenian Emmons, Nancy E Byerly, Narahi J Alvarez Alcazar, Nathan M Jornod, Nathan R Moon, Neil J Traaen, Neira Acevedo Ramos, Nicholas R Nance, Norman Wong, Oluwaseyi Ojinni, Omotunde O Osunsanmi, Patricia A Brown, Patricia A Maestas, Paul M Kawamoto, Paula A Trost, Phillip M Pontikos, Prabhu P Raju, Rachelle M Deskins, Rebecca L Mullikin, Rebecca T Davis, Richard A Martin, Richard G Runyon, Robert F Hennes, Rocco C Black, Ronald E Gill, S Lori Brown, PhD MPH, Samantha E Rafferty, Savini, Scott A Nabe, Secrist, Shahriar Rahmani, Sharon I Gundersen, Sheila Alaghemand, Shelagh D Schopen, Shelley H Beausoleil, Shererk, Sherri N Rohlf, MD, Sherryl Stoltenow, Stanley B Eugene, BS, BME, State Agency, Stephen R Souza, Sunitha K Rajaram, PhD, Thai T Duong, Theressa B Smith, Timothy D Evans, V Teres Speer, Vicky L Cruz, Victor A Meo, William A Burkey, William A Lanier, Xiaojun Yan, Zachary L Stamm

Philip E Ake's Documents

Publish Date Document Type Title
August, 2002 EIR Quorum Review Inc. - EIR, 2002-08-30
July, 2003 FDA 483 Sybronendo, Div of Ormco Corp - Form 483, 2003-07-24
August, 2003 FDA 483 Philips North America LLC - Form 483, 2003-08-19
July, 2003 EIR Sybronendo, Div of Ormco Corp - EIR, 2003-07-24
September, 2003 EIR United Contact Lens, Inc. - EIR, 2003-09-30
August, 2003 EIR Lacrimedics Inc - EIR, 2003-08-01
August, 2003 FDA 483 Response Philips North America LLC - Form 483R, 2003-08-22
August, 2003 EIR Welch Allyn Protocol, Inc - EIR, 2003-08-22
August, 2003 FDA 483 Response Lacrimedics Inc - Form 483R, 2003-09-19
August, 2003 EIR Philips North America LLC - EIR, 2003-08-19
September, 2003 FDA 483 United Contact Lens, Inc. - Form 483, 2003-09-30
September, 2003 EIR SurgiMark, Inc. - EIR, 2003-09-16
September, 2003 EIR Biodynamics Corporation - EIR, 2003-09-23
August, 2003 FDA 483 Welch Allyn Protocol, Inc - Form 483, 2003-08-22
September, 2003 FDA 483 SurgiMark, Inc. - Form 483, 2003-09-16
August, 2003 FDA 483 Response Welch Allyn Protocol, Inc - Form 483R, 2003-08-27

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more